Introduction

Our Success

Management

Milestones and Pipeline

SquiCor LLC®‘s focus this past year has been on rigorous execution of our strategy of building the Company’s two core businesses, namely therapeutic and diagnostic peptides in the field of oncology, and we can look back on excellent progress in both areas.

The successful and timely execution of our dual strategy was clearly reflected in our discovery of a new class of molecules and our pre-clinical test results that included internalization studies, cytotoxicity studies (cell killing studies), biodistribution studies and animal therapeutic studies.